Merit Financial Group »

Sarepta Therapeutics shares owned by Merit Financial Group

Quarter-by-quarter ownership of Sarepta Therapeutics (SRPT) shares owned by Merit Financial Group from 13F filings

Historical chart of Merit Financial Group investment in Sarepta Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics held by Merit Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics by Merit Financial Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $820k 38k 21.52

More positions owned by Merit Financial Group

Vanguard Index Fds Growth Etf (VUG)
Gmo Etf Trust Gmo Us Quality E (QLTY)
Ishares Tr Core S&p Us Gwt (IUSG)
Ishares Tr Core S&p Us Vlu (IUSV)
Vanguard World Mega Grwth Ind (MGK)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Value Etf (VTV)
NVIDIA Corporation (NVDA)
Vanguard World Mega Cap Val Etf (MGV)
Microsoft Corporation (MSFT)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Core Msci Emkt (IEMG)
Spdr Series Trust State Street Spd (SPTI)
Ishares Tr Eafe Value Etf (EFV)

View all positions for Merit Financial Group

Top funds holding Sarepta Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Susquehanna International
Erste Asset Management GmbH
Standard Life Aberdeen
Two Sigma Investments
D. E. Shaw & Co
UBS Group
First Trust Advisors
Two Sigma Advisers
Geode Capital Management
LMR Partners
Citadel Advisors
AQR Capital Management

View all funds holding Sarepta Therapeutics